Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Covetrus Inc (CVET) NPV

Sell:$36.99 Buy:$37.03 Change: $0.79 (2.18%)
NASDAQ:0.99%
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
Sell:$36.99
Buy:$37.03
Change: $0.79 (2.18%)
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
Sell:$36.99
Buy:$37.03
Change: $0.79 (2.18%)
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Covetrus, Inc is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy services. The Company’s offered solutions include supply chain services, software solutions and prescription management.

Contact details

Address:
7 Custom House St
PORTLAND
04101-4185
United States
Telephone:
+1 (631) 8435500
Website:
https://covetrus.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CVET
ISIN:
US22304C1009
Market cap:
$4.61 billion
Shares in issue:
127.52 million
Sector:
Health Care Distributors
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Philip Laskawy
    Independent Chairman of the Board
  • Benjamin Wolin
    President, Chief Executive Officer, Director
  • Matthew Foulston
    Global Chief Financial Officer
  • Matthew Malenfant
    President, Customer Operations - North America
  • Michael Ellis
    Executive Vice President, President - Europe and North America
  • David Hinton
    Executive Vice President, President - APAC and Emerging Marke
  • Timothy Ludlow
    Executive Vice President, Chief Transformation Officer
  • Anthony Providenti
    Executive Vice President, Corporate Development
  • Georgina Wraight
    Executive Vice President, President - Global Technology Solutions
  • Erin Brennan
    Senior Vice President, General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.